POINT
PNTPOINT Biopharma Price (PNT)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
96,034,506
(30.0385)%Revenue and Profitability
| Year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 226,579,563 |
| Net Income | -36,896 | -13,373,003 | -45,902,481 | 98,293,213 |
| FCF USD | 0 | -18,100,256 | -53,500,940 | 170,752,100 |
| OCF USD | 0 | -8,302,856 | -44,698,758 | 183,518,622 |
Financial Health - DEBT
| Year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| YTPD | 0.00 | -0.27 | 0.00 | 0.00 |
| D/E | 0.00 | 0.26 | 0.00 | 0.00 |
| CA/CL | 0.11 | 2.40 | 30.56 | 6.66 |
| TA/TL | 0.11 | 2.55 | 32.72 | 6.33 |
| Total Debt | 0 | 3,550,660 | 0 | 0 |
Management Performance
| Year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| ROIC | 383.27% | -77.52% | -17.95% | 19.55% |
| ROE | 400.00% | -99.20% | -17.99% | 20.19% |
| ROA | 0.00% | -60.25% | -17.44% | 17.00% |
| NM % | - | - | - | 43.38% |
| FCF / R% | 0.00% | 0.00% | 0.00% | 75.36% |
| FCF / NI% | 0.00% | 135.35% | 116.55% | 173.72% |
| Operating Margin (OM) | - | - | - | 0.17 |
Per Share
| Year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| EPS | 0.00 | -0.34 | -0.62 | 1.04 |
| SPS | 0.00 | 0.00 | 0.00 | 2.40 |
| OCPS | 0.00 | -0.21 | -0.61 | 1.94 |
| FCPS | 0.00 | -0.47 | -0.72 | 1.80 |
| BVPS | 0.00 | 0.35 | 3.46 | 5.15 |
Per Share - CAGR
| Year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| CAGR-EPS | 0.00 | -0.34 | -0.62 | 1.04 |
| CAGR-SPS | 0.00 | 0.00 | 0.00 | 2.40 |
| CAGR-OCPS | 0.00 | -0.21 | -0.61 | 1.94 |
| CAGR-FCPS | 0.00 | -0.47 | -0.72 | 1.80 |
| CAGR-BVPS | 0.00 | 0.35 | 3.46 | 5.15 |